BIOXYTRAN, INC (BIXT)
About BIOXYTRAN, INC
BIOXYTRAN INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $191.1K
- Net income
- -$2.1M
- Total assets
- $658.6K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Bioxytran, Inc (BIXT) Stock Price
- Reported a net loss of $2.1M in FY2017.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BIOXYTRAN, INC.
Write a review
News about BIOXYTRAN, INC
News & sentiment via Polygon.io
Bioxytran, Inc: frequently asked questions
Is Bioxytran, Inc an American company?
Bioxytran, Inc is a US-based company headquartered in Needham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bioxytran, Inc headquartered?
Bioxytran, Inc is headquartered in Needham, Massachusetts, United States.
Is Bioxytran, Inc publicly traded?
Yes — Bioxytran, Inc is a publicly traded company. Its stock trades under the ticker symbol BIXT on the OTC.
What does Bioxytran, Inc do?
Bioxytran, Inc is an American Pharmaceuticals company in the Health & Beauty sector.
